TY - JOUR
T1 - Epinephrine Autoinjector Prescribing Trends
T2 - An Outpatient Population-Based Study in Olmsted County, Minnesota
AU - Lee, Sangil
AU - Hess, Erik P.
AU - Lohse, Christine
AU - Souza, Dante Lucas S.
AU - Campbell, Ronna L.
N1 - Funding Information:
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and by Clinical and Translational Science Award Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
Funding Information:
Conflicts of interest: S. Lee has received research support from the Mayo Foundation; and has received travel support from Food Allergy Research and Education. R. L. Campbell has received consultancy fees from INSYS; has received lecture fees from the American College of Allergy, Asthma and Immunology; and receives royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts.
Publisher Copyright:
© 2016 American Academy of Allergy, Asthma & Immunology
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background The prescribing pattern of epinephrine over time is an indicator of the secular trend of anaphylaxis. However, it is not well known in a population level in the United States. Objective To evaluate the trend of prescriptions for epinephrine autoinjectors in Olmsted County, Minn, residents. Methods Outpatient prescriptions for epinephrine were identified among residents of Olmsted County, Minn, between January 1, 2004, and December 31, 2010. We used the first prescription per patient per year, and the first prescription per patient during the study period to calculate incidence rates. Incidence rates per 100,000 person-years were calculated using patients prescribed epinephrine per year as the numerator and age- and sex-specific counts of the population of Olmsted County as the denominator. The relationships of age group, sex, and year of prescription with incidence rates were assessed by fitting Poisson regression models using the SAS procedure GENMOD. Results The overall incidence rate of epinephrine autoinjector prescriptions during the study period was 757 per 100,000 person-years (95% confidence interval: 740-774). The prescription rates per patient per year increased over time, with an annual rate of increase of 8% (P < .001), but the rates per patient remained stable (P = .077). For each year, incidence rates overall were higher in women compared with men (P < .001). From ages 0 to 19, incidence rates were higher in boys compared with girls. At age 20 and above, incidence rates were higher in women compared with men. Conclusions The overall rate of epinephrine autoinjector prescriptions increased, but the rate of first-time prescriptions was stable from 2005 to 2010. In childhood, boys were more likely to receive a prescription than girls, but this reversed in later ages.
AB - Background The prescribing pattern of epinephrine over time is an indicator of the secular trend of anaphylaxis. However, it is not well known in a population level in the United States. Objective To evaluate the trend of prescriptions for epinephrine autoinjectors in Olmsted County, Minn, residents. Methods Outpatient prescriptions for epinephrine were identified among residents of Olmsted County, Minn, between January 1, 2004, and December 31, 2010. We used the first prescription per patient per year, and the first prescription per patient during the study period to calculate incidence rates. Incidence rates per 100,000 person-years were calculated using patients prescribed epinephrine per year as the numerator and age- and sex-specific counts of the population of Olmsted County as the denominator. The relationships of age group, sex, and year of prescription with incidence rates were assessed by fitting Poisson regression models using the SAS procedure GENMOD. Results The overall incidence rate of epinephrine autoinjector prescriptions during the study period was 757 per 100,000 person-years (95% confidence interval: 740-774). The prescription rates per patient per year increased over time, with an annual rate of increase of 8% (P < .001), but the rates per patient remained stable (P = .077). For each year, incidence rates overall were higher in women compared with men (P < .001). From ages 0 to 19, incidence rates were higher in boys compared with girls. At age 20 and above, incidence rates were higher in women compared with men. Conclusions The overall rate of epinephrine autoinjector prescriptions increased, but the rate of first-time prescriptions was stable from 2005 to 2010. In childhood, boys were more likely to receive a prescription than girls, but this reversed in later ages.
KW - Anaphylaxis
KW - Epidemiology
KW - Epinephrine autoinjector
KW - Incidence rate
UR - http://www.scopus.com/inward/record.url?scp=84973582208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84973582208&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2016.05.006
DO - 10.1016/j.jaip.2016.05.006
M3 - Article
C2 - 27283053
AN - SCOPUS:84973582208
SN - 2213-2198
VL - 4
SP - 1182-1186.e1
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 6
ER -